Medacta Group SA
Research Medacta Group SA (MOVE.SW) on Bullrun: market cap CHF 2.26B, P/E 31.0, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMOVE.SW
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyCHF
- Market capCHF 2.26B
- P/E31.0
- Dividend yield1.0%
- Financial periodFY2025
- RevenueEUR 683.83M
- Revenue growth15.8%
- Net incomeEUR 95.46M
- Free cash flowEUR 9.55M
- Gross margin67.1%
Valuation Snapshot
latest market cap is CHF 2.26B; P/E is 31.0; dividend yield is 1.0%.
Peer valuation comparison
Latest P/E is 30.98x versus a Healthcare sector median of 24.67x (25.6% above).
Latest dividend yield is 0.96% versus a Healthcare sector median of 1.84% (47.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 683.83M | EUR 95.46M | EUR 9.55M | 67.1% | n/a | EUR 33.21M | EUR 260.76M | EUR 456.58M |
| FY2024 | EUR 590.58M | EUR 72.89M | EUR 2.45M | 67.6% | 3.65 | EUR 31.59M | EUR 241.21M | EUR 379.66M |
| FY2023 | EUR 510.78M | EUR 47.36M | -EUR 7.09M | 68.1% | 2.37 | EUR 20.79M | EUR 201.98M | EUR 330.04M |
| FY2022 | EUR 437.12M | EUR 46.25M | EUR 2.25M | 69.8% | 2.31 | EUR 32.26M | EUR 170.25M | EUR 274.66M |
| FY2021 | n/a | n/a | n/a | n/a | 2.58 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | CHF 2.26B | 31.0 | 1.0% | 1.1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.1 CHF, yield 1.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.69 EUR |
| FY2024 | 0.55 EUR |
| FY2023 | 0.27 EUR |
| FY2022 | 0.54 EUR |
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Medacta Group SA's market cap?
Medacta Group SA's market capitalization is CHF 2.26B.
What is Medacta Group SA's P/E ratio?
Medacta Group SA's price-to-earnings (P/E) ratio is 31.0.
Does Medacta Group SA pay a dividend?
Medacta Group SA has a dividend yield of 1.0%.
What does Medacta Group SA do?
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.